Whistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.
Brian Dickerson
Advertisement
Articles by Brian Dickerson
Legislation seeks to fight drug cost increases by creating transparency in the pricing activities of manufacturers and pharmacy benefit managers.
Advertisement
Latest Updated Articles
State-Level Diabetes Drug-Pricing Transparency Bills Target PBMsPublished: August 2nd 2017 | Updated:
Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims AllegationsPublished: August 9th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
2
Integrating Combination Therapies for Type 2 Diabetes and CKD
3
Building a Unified Approach to Cardio Kidney Metabolic Health
4
SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence
5
